The European Union (EU) and most of all of its member states take antitrust and competition laws very seriously. This is evidenced by the aggressive investigation and prosecution of suspected violators, the frequent assertion of more restrictive interpretation of applicable standards than their U.S. counterparts, and the severe damages that can be assessed against companies who do not comply.
Foley hosted the third Web conference in our three-part series covering the latest in the EU’s antitrust laws. The three topics to be discussed include:
- European Community and EU member state merger control policies, procedures, and remedies
- European competition law and procedures, including vertical restraints, technology licensing, and cartel enforcement
- Trends and developments in European competition law, including privilege, private remedies, class actions, and best practices for compliance
People
Related Insights
22 April 2025
Health Care Law Today
Health Care Marketing: The Seventh Circuit Addresses “Referrals” Under The Anti-Kickback Statute
The case, United States v. Sorenson, addressed whether a Medicare-registered distributor violated the AKS in making payments to advertising, marketing, and manufacturing companies that worked to sell orthopedic braces to Medicare patients. The court held that such payments were not “referrals” within the meaning of the AKS because the payments were made to entities that were neither physicians in a position to refer their patients nor other decisionmakers in positions to “leverage fluid, informal power and influence” over health care decisions.
22 April 2025
Health Care Law Today
Skilled Nursing Facilities: CMS Extends Medicare Revalidation Deadline
On April 17, 2025, the Centers for Medicare and Medicaid Services (CMS) announced another extension of the deadline by which skilled nursing facilities (SNFs) must revalidate their Medicare enrollments.
21 August 2025
Events
6th Clinical Trial Agreements Summit
Foley partners Monica Chmielewski, vice chair of the firm’s Health Care Practice Group, Kyle Faget, and Nate Beaver, co-chairs of the firm’s Medical Devices Area of Focus, are speaking at Dynamic Global Events’ 6th Clinical Trial Agreements (CTA) Summit on August 21-22.